Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
NB
NOVOZYMES BIOINDUSTRIAL A/S
aktivCVR 24257908AktieselskabKrogshøjvej 36, 2880 BagsværdIkke-finansielle holdingselskaber
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 27 Sept 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
DKK -52.1k
Latest period
Source details
Source: dk-regnskabsdata-live-24257908-1790525193038
Document: dk-regnskabsdata-24257908-AZ6NZQUJHpprI11O6beX-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: ctx-1
Unit: dkk
Net result
DKK -44.2k
Latest period
Source details
Source: dk-regnskabsdata-live-24257908-1790525193038
Document: dk-regnskabsdata-24257908-AZ6NZQUJHpprI11O6beX-1
XBRL: fsa:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: ctx-1
Unit: dkk
Equity
DKK 24.9m
Equity ratio: 99.8%
Source details
Source: dk-regnskabsdata-live-24257908-1790525193038
Document: dk-regnskabsdata-24257908-AZ6NZQUJHpprI11O6beX-1
XBRL: fsa:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: ctx-3
Unit: dkk
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK -3m |
| 2023 | — | DKK -4m |
| 2024 | — | DKK -41.7k |
| 2025 | — | DKK -44.2k |